Publication | Open Access
Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019
20
Citations
10
References
2020
Year
Viral DiagnosticsPrognosisImmunologyMolecular Inflammatory ResponseCovid-19 EpidemiologyCovid-19Viral PersistenceClinical EpidemiologyHematologyPublic HealthCoronavirus Disease 2019Long CovidDisease Risk AssessmentCovid-19 PandemicRiskVirologyEpidemiologyPrognostic EvaluationRisk-stratifying Covid-19 PatientsMedicineHemophagocytic Lymphohistiocytosis Hscore
The clinical manifestation of moderate to severe coronavirus disease 2019 (COVID-19) has parallels to secondary hemophagocytic lymphohistiocytosis (HLH) both clinically and based on molecular inflammatory response. We found no evidence to support the utility of risk-stratifying COVID-19 patients using risk scoring methodology designed for HLH.
| Year | Citations | |
|---|---|---|
Page 1
Page 1